Brief: Bausch + Lomb Q2 Adjusted EPS USD 0.15 Vs. IBES Estimate USD 0.15
29/07/2026 11:59
BRIEF-Bausch + Lomb Q2 Adjusted EPS USD 0.15 Vs. IBES Estimate USD 0.15 Jul 29 (Reuters) - Bausch + Lomb Q2 operating income USD 83 million.
- Q2 revenue USD 1,394 million vs. IBES estimate USD 1,369 million
- Q2 net income USD -14 million
- Q2 adjusted net income USD 55 million vs. IBES estimate USD 54.9 million
- Q2 adjusted EBITDA USD 241 million vs. IBES estimate USD 236.5 million
- Q2 EPS USD -0.04
- Outlook FY revenue USD 5,440-5,540 million
Recent news on Bausch + Lomb
See all newsBausch + Lomb CEO Saunders departs, Chairman Appio named interim chief (updated)
Brief: Bausch + Lomb And Bausch Health Announce Appointment Of Thomas J. Appio As Interim Bausch + Lomb CEO, Expect To Raise Full-Year 2026 Guidance
Bausch + Lomb CEO Saunders steps down, Chairman Appio appointed interim chief
Brief: US FDA sent warning letter to Bausch & Lomb on September 4
Brief: Bausch + Lomb Announces European CE Mark Approval Of Seelyra™ Femtosecond Laser